je.st
news
FDA declines expanded approval for Bristol-Myers' Opdivo drug
2015-11-28 01:31:21| Biotech - Topix.net
REUTERS: Bristol-Myers Squibb Co said the U.S. Food and Drug Administration declined to approve its immuno-oncology drug, Opdivo, for its expanded use to treat an additional type of advanced skin cancer. Bristol-Myers said it received a so-called complete response letter from the health regulator, which indicated the need for additional data in the BRAF mutated patient population.
Tags: drug
expanded
approval
fda
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|
|||